MOMA THERAPEUTICS
MOMA Therapeutics operates as a biotechnology company. MOMA Therapeutics discover the next generation of precision medicines by targeting the molecular machines that underlie human disease.
MOMA THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2020-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.momatx.com
Total Employee:
51+
Status:
Active
Contact:
(617) 936-0384
Total Funding:
236 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager WordPress Domain Not Resolving Sitelinks Search Box Euro Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins
Similar Organizations
Atomic Agro
Atomic Agro operates as an agrotech startup company.
Cygnal Therapeutics
Cygnal Therapeutics is a biotechnology company
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
Eyebiotech
Eyebiotech is a privately held ophthalmology biotechnology company.
Faze Medicines
Faze Medicines is a biotechnology company.
Gooal Gene
Gooal Gene operates as an ag-biotechnology company.
Janpix
Janpix operates as an oncology-focused startup.
Kovina Therapeutics
Kovina Therapeutics operates as a pre-clinical biotechnology company.
LIG Biowise
Manchester, UK-based biotechnlogy company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Neuroene Therapeutics
Neuroene Therapeutics is a startup biotechnology company.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
PEEL Therapeutics
PEEL Therapeutics is a Biotechnology company.
Rain Therapeutics
Rain Therapeutics is a operator of a clinical stage biotechnology company.
Recida Therapeutics
Recida Therapeutics is a Biotechnology company.
RubrYc Therapeutics
RubrYc Therapeutics is a biotechnology company.
Terray Therapeutics
Terray Therapeutics is a biotechnology company that propels drug discovery into the information age.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Advisors List
Current Employees Featured
Founder
Investors List
LifeSci Venture Partners
LifeSci Venture Partners investment in Series B - MOMA Therapeutics
Pavilion Capital
Pavilion Capital investment in Series B - MOMA Therapeutics
Goldman Sachs Asset Management
Goldman Sachs Asset Management investment in Series B - MOMA Therapeutics
Creacion Ventures
Creacion Ventures investment in Series B - MOMA Therapeutics
Nextech Invest
Nextech Invest investment in Series B - MOMA Therapeutics
Rock Springs Capital
Rock Springs Capital investment in Series B - MOMA Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - MOMA Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series B - MOMA Therapeutics
Invus
Invus investment in Series B - MOMA Therapeutics
Casdin Capital
Casdin Capital investment in Series B - MOMA Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-07 | MOMA Therapeutics Appoints Hans Bitter, Ph.D., As Senior Vice President And Head, Data Science |
Official Site Inspections
http://www.momatx.com Semrush global rank: 5.09 M Semrush visits lastest month: 1.61 K
- Host name: 117.120.82.34.bc.googleusercontent.com
- IP address: 34.82.120.117
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "MOMA Therapeutics"
Team - MOMA Therapeutics
We are drug discovery professionals. We are industry specialists. We have a responsibility to tackle this challenge. Leadership. Founders. InvestorsSee details»
MOMA Therapeutics
We will discover the next generation of precision medicines by targeting the molecular machines that underlie human disease.See details»
Science – MOMA Therapeutics
Our organization is purpose-built and laser-focused on tackling the unique challenges and opportunities inherent to this drug class. What sets MOMA apart is our fully integrated approach to therapeutic discovery that unites cutting …See details»
MOMA Therapeutics - LinkedIn
MOMA Therapeutics is a clinical-stage, next-generation precision medicine company dedicated to targeting highly dynamic proteins that underlie human disease via a small molecule approach ...See details»
MOMA Therapeutics - Crunchbase Company Profile
MOMA Therapeutics operates as a biotechnology company. MOMA Therapeutics discover the next generation of precision medicines by targeting the molecular machines that underlie human disease.See details»
MOMA Therapeutics Company Profile | Management and …
[email protected]: MOMA Therapeutics Top Competitors. Company Employees Revenue Top technologies; TetraGenetics Inc. 15: $2.4 M: X-Chem Inc. 147: $21.9 M: Arrakis Therapeutics …See details»
MOMA Therapeutics, Inc. - Drug pipelines, Patents, Clinical
6 days ago For more information, go to www.momatx.com . 19 Aug 2024 ... The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as …See details»
MOMA Therapeutics Management Team | Org Chart - RocketReach
MOMA Therapeutics employs 71 employees. The MOMA Therapeutics management team includes Asit Parikh (President and Chief Executive Officer at MOMA Therapeutics), Semi …See details»
MOMA Therapeutics - Overview, News & Similar companies
Jan 4, 2024 MOMA Therapeutics Announces Five-Year Discovery Collaboration with Roche Focused on Critical Cancer Dependencies CAMBRIDGE, Mass.--(BUSINESS WIRE)--MOMA …See details»
MOMA – MOMA Therapeutics
We’re focused on discovering the next generation of precision medicines. We’ll do this by bringing seminal scientific advancements in biochemistry, biophysics, structural biology, chemistry, and functional genomics to the table as one team.See details»
MOMA Therapeutics to Participate in Upcoming Investor …
CAMBRIDGE, Mass., November 06, 2024--MOMA Therapeutics, Inc., a clinical-stage biopharmaceutical company discovering and developing a new generation of precision …See details»
MoMa Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for MoMa Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Moma Therapeutics - VentureRadar
Develops and manufactures advanced enzyme-based products for various industries, including pharmaceuticals, biofuels, and environmental solutions, utilizing innovative molecular technology.See details»
MOMA Therapeutics Company Overview, Contact Details
Momatx is developing small molecule oncology program on Oct 8th '24. BERLIN & CAMBRIDGE, Mass.-(BUSINESS WIRE)-Bayer and MOMA Therapeutics, Inc., a clinical-stage …See details»
MOMA Therapeutics Appoints Marc Ballas, M.D., as Head of …
Jun 25, 2024 “I am thrilled to work with our talented team to uphold this authentic foundation and help MOMA grow and thrive in our new era as a clinical organization.” Marc Ballas, M.D. Dr. …See details»
MOMA Therapeutics - Remote
MOMA Therapeutics is a clinical-stage, next-generation precision medicine company dedicated to targeting highly dynamic proteins that underlie human disease via a small molecule approach, …See details»
MOMA Therapeutics - workinbiotech.com
MOMA Therapeutics is targeting the molecular machines that drive disease with precision medicine. Molecular machines present compelling therapeutic opportunities for disease …See details»
MOMA Therapeutics to Participate in Upcoming Investor …
CAMBRIDGE, Mass., November 6, 2024 — MOMA Therapeutics, Inc., a clinical-stage biopharmaceutical company discovering and developing a new generation of precision …See details»
MOMA Therapeutics - ContactOut
We’re on a mission to unlock molecular machines by understanding and respecting their complexities. We’ll be working incredibly hard to discover their untapped potential because we …See details»
Bayer and MOMA Therapeutics enter collaboration and license …
Oct 8, 2024 By focusing on genetically validated targets with high translation potential, MOMA is rapidly advancing its pipeline toward responses in the clinic. For more information, go to …See details»